Arslan Ümit, Yıldız Ziya, Pir İbrahim, Aykut Çağrı
Department of Cardiovascular Surgery, Faculty of Medicine, Atatürk University, Erzurum 25030, Turkey.
Department of Cardiovascular Surgery, Erzurum City Hospital, Erzurum 25040, Turkey.
Life (Basel). 2025 Mar 8;15(3):426. doi: 10.3390/life15030426.
Abdominal aortic aneurysms (AAAs) are life-threatening conditions that require timely intervention to prevent rupture. Endovascular aneurysm repair (EVAR) is preferred due to faster recovery and lower perioperative risk; however, intraoperative failure and long-term complications highlight the continued significance of open surgical repair (OSR) and the need for improved risk assessment. This retrospective study analyzed data from 210 patients who underwent EVAR ( = 163) or OSR ( = 47) at a single center. Clinical characteristics, complications, reintervention rates, and 30-day mortality were recorded. EVAR-to-OSR conversion and mortality predictors in AAA treatments were identified. : The overall mortality rate was 9.5% (20/210 patients), with 12 patients (7.3%) in the EVAR group and 8 patients (17%) in the OSR group ( = 0.085). Five patients required early and six required late conversion to open surgery. In follow-ups beyond 30 days, the reintervention rate for EVAR was higher (HR: 1.2, 95% CI: 0.4-3.6; = 0.754). According to the multivariable analysis, rupture ( = 0.045), female sex ( = 0.018), body weight ( = 0.003), and aortic size index ( = 0.019) were significant predictors of mortality, whereas OSR was not ( = 0.212). : Treatment optimization requires a balanced approach, integrating both EVAR and OSR based on patient-specific factors. Maintaining expertise in both techniques is essential to ensure the best possible outcomes, and OSR should remain a viable option when clinically indicated.
腹主动脉瘤(AAA)是危及生命的疾病,需要及时干预以防止破裂。由于恢复更快且围手术期风险更低,血管内动脉瘤修复术(EVAR)是首选;然而,术中失败和长期并发症凸显了开放手术修复(OSR)的持续重要性以及改进风险评估的必要性。这项回顾性研究分析了在单一中心接受EVAR(n = 163)或OSR(n = 47)的210例患者的数据。记录了临床特征、并发症、再次干预率和30天死亡率。确定了AAA治疗中EVAR转为OSR以及死亡率的预测因素。结果:总死亡率为9.5%(210例患者中的20例),其中EVAR组有12例患者(7.3%),OSR组有8例患者(17%)(P = 0.085)。5例患者需要早期转为开放手术,6例需要晚期转为开放手术。在30天以上的随访中,EVAR的再次干预率更高(HR:1.2,95%CI:0.4 - 3.6;P = 0.754)。根据多变量分析,破裂(P = 0.045)、女性(P = 0.018)、体重(P = 0.003)和主动脉大小指数(P = 0.019)是死亡率的显著预测因素,而OSR不是(P = 0.212)。结论:治疗优化需要一种平衡的方法,根据患者的具体因素整合EVAR和OSR。保持两种技术的专业知识对于确保获得最佳结果至关重要,并且当临床指征明确时,OSR应仍然是一种可行的选择。